Multispecific Organic Anion Transporter Is Responsible for the Biliary Excretion of the Camptothecin Derivative Irinotecan and its Metabolites in Rats

References

Page 1

	Year	Citations
Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Yasuyoshi Kawato, Masashi Aonuma, Yasuhide Hirota, PubMed Medicinal ChemistryChemoprevention StrategyCamptothecin Derivative Cpt-11MedicinePharmacology	1991	874
Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea. E Gupta, Timothy M. Lestingi, Rosemarie Mick, PubMed Metabolic FateGastrointestinal PharmacologyGastroenterologyPathologyPharmacotherapy	1994	506
A kinetic and Mechanistic Study of the Hydrolysis of Camptothecin and Some Analogues Julianne Fassberg, Valentino J. Stella Journal of Pharmaceutical Sciences EngineeringBiotransformationBiochemistryBioenergeticsBiocatalysis	1992	462
Modification of the hydroxylactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity Robert Hertzberg, Mary Jo Caranfa, Kenneth G. Holden, Journal of Medicinal Chemistry	1989	411
Validation of a recording spectrophotometric method for measurement of membrane-associated Mg- and NaK-ATPase activity. Bruce F. Scharschmidt, E B Keeffe, Nancy M. Blankenship, PubMed	1979	353
The structural basis of camptothecin interactions with human serum albumin: impact on drug stability Thomas G. Burke, Zihou Mi Journal of Medicinal Chemistry Pharmaceutical ScienceLactone FormsPharmaceutical ChemistryDrug ResistanceMedicinal Chemistry	1994	326
ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. Toshihisa Ishikawa, Michael Müller, Cornelia Klünemann, Journal of Biological Chemistry Liver Canalicular MembraneLipid MovementRedox BiologyCellular PhysiologyOxidative Stress	1990	304
Phase I and pharmacokinetic trial of weekly CPT-11. Mace L. Rothenberg, John G. Kuhn, Howard A. Burris, Journal of Clinical Oncology Therapeutic Drug MonitoringOncologyDrug InfusionHealth SciencesDose Levels	1993	301
Comparison of Topoisomerase I Inhibition, DNA Damage, and Cytotoxicity of Camptothecin Derivatives Presently in Clinical Trials Akihiko Tanizawa, A. Fujimori, Yoshihiro Fujimori, JNCI Journal of the National Cancer Institute	1994	297
Metabolism and pharmacokinetics of the camptothecin analogue CPT-11 in the mouse. N Kaneda, Hiroko Nagata, T Furuta, PubMed Antitumor ActivityChemoprevention StrategyCamptothecin Analogue Cpt-11Cellular PharmacologyPharmacotherapy	1990	293

Page 1